tirzepatide with nad+ and b12 Sleep Support+ | GLP-1 & L-Theanine Compound Tirzepatide
Description
Low Starting Dose Dose per injection: 2.5 mg 50 units (0.50 mL) on a U-100 insulin syringe Frequency: once weekly, subcutaneous (same day each week) Cycle length: 816 weeks (step up every 4 weeks) Weeks 14 starting dose
State FDA pen (Mounjaro / Zepbound) Storage 35.646.4 F (28 C)
Compounding pharmacies create their medications by obtaining tirzepatide API, the raw chemical, and mixing it into a single dose final formulation
This draws room air into the barrel
It is approved for chronic weight management in adults and children 6 years and older with obesity due to specific genetic conditions, including proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency, or Bardet-Biedl syndrome
Increase activity variety: If you have been only walking and doing weights, add interval training once weekly
